CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China) Blood CSF1 and CXCL12 as Causal Mediators of Coronary Artery Disease Cardiac monocytes and macrophages after myocardial infarction Symptom-Onset-To-Balloon Time, ST-Segment Resolution and In-Hospital Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention in China: From China Acute Myocardial Infarction Registry Clinical Impact of Valvular Heart Disease in Elderly Patients Admitted for Acute Coronary Syndrome: Insights From the Elderly-ACS 2 Study Coronary Catheterization and Percutaneous Coronary Intervention in China: 10-Year Results From the China PEACE-Retrospective CathPCI Study Validation of High-Risk Features for Stent-Related Ischemic Events as Endorsed by the 2017 DAPT Guidelines

Review Article2020 Jun 27;9(7):E2020.

JOURNAL: J Clin Med . Article Link

Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome

W Bor, DA Gorog. Keywords: NOAC; ACS; antiplatelet therapy; antithrombotic therapy; atrial fibrillation; dual therapy; oral anticoagulants; percutaneous coronary intervention; triple therapy; vitamin K antagonist

Full Text PDF